Recently, KornnacCaps reached another important milestone in its internationalization journey-a batch of high-quality Size 0 gelatin capsules has successfully completed production and rigorous quality testing. The products have been officially packed and shipped, embarking on their journey to France. This not only marks KornnacCaps's further expansion in the European market but also once again highlights the global competitiveness of "Made in China" in the pharmaceutical excipient sector.
The Size 0 gelatin capsules exported to France this time represent one of the most popular and widely applied specifications in the pharmaceutical and health supplement industry. Addressing the high standards required for health products in the French and broader European markets, KornnacCaps has meticulously refined its R&D and production processes. This batch of Size 0 capsules utilizes premium pharmaceutical-grade gelatin as its primary raw material, featuring excellent solubility and bioavailability, making it perfectly compatible with the filling processes of various powders, granules, and pellets.
Additionally, leveraging the ergonomic design advantages of Size 0 capsules-such as "moderate capacity and easy to swallow"-the product significantly enhances the end-consumer's swallowing experience. In terms of physical performance, these capsules exhibit exceptional toughness and low friability. This ensures smooth operation on high-speed automated filling production lines, minimizing the risk of breakage or deformation, and perfectly meeting the stringent requirements of French customers for large-scale production.
As an enterprise committed to providing high-quality capsule solutions to global clients, KornnacCaps has always regarded product quality as the lifeblood of the company. For the Size 0 gelatin capsules shipped to France, every process-from raw material procurement, gel melting, dipping, and drying to demolding and sorting-strictly adheres to international GMP standards. Prior to shipment, all products undergo stringent microbiological control, heavy metal testing, and moisture content analysis. This ensures that all indicators not only meet the Chinese Pharmacopoeia standards but also fully comply with the strict regulations of the European Pharmacopoeia (EP).
Behind this high quality lies KornnacCaps's ultimate pursuit of detail and profound understanding of international regulations. This provides a robust quality endorsement for French customers and lays a solid foundation for establishing a long-term, stable strategic partnership between both parties.
As a significant pharmaceutical and health supplement market in Europe, France imposes extremely high market access thresholds. The successful shipment to the French client this time serves as a powerful validation of KornnacCaps's R&D, manufacturing capabilities, and quality control systems. It also injects strong momentum into the company's expansion into the broader European landscape.
Looking ahead, KornnacCaps will constantly optimize its product structure and elevate its service levels. Taking the smooth delivery of this French order as an opportunity, KornnacCaps will continue to provide safe, reliable, and efficient capsule products to global partners, empowering the thriving development of the global health industry.
